This document contains Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers about the use of Bexsero®, a recombinant multicomponent meningococcal B vaccine (4CMenB).
It includes information about transport, storage and handling, dosage and administration, recommendations, contraindications, adverse events and references to more detailed information.
ATAGI advice on the use of Bexsero® vaccine
About this resource
Publication date:
Publication type:
Guideline
Language:
English